BioSpace News Archive

Vir Biotechnology, Inc. announced that George Scangos, Ph.D., chief executive officer, will highlight the Company’s expected 2023 catalysts and long-term growth strategy at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, at 9:45 a.m. PT / 12:45 p.m. ET.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 41st Annual J.P. Morgan Healthcare Conference at 11:15 a.m. Pacific Time on Monday Jan. 9, 2023 in San Francisco.

Berkeley Lights, Inc., a life sciences tools company, announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

Karyopharm Therapeutics Inc. announced that the Company granted stock options to purchase an aggregate of 24,300 shares of Karyopharm’s common stock and an aggregate of 16,600 restricted stock units to four newly-hired employees.

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 2,000 shares of Akebia’s common stock on December 30, 2022, as an inducement material to such employee entering into employment with Akebia.

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present a company overview and participate in a Q&A session at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 9:45 am PT at The Westin St. Francis in San Francisco.

Exelixis, Inc. announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 8:15pm ET / 5:15pm PT.

Coya Therapeutics, Inc. (“Coya” or the “Company”) (Nasdaq: COYA) today announced the closing of its initial public offering of 3,050,000 shares of its com mon stock and accompanying warrants to purchase up to 1,525,000 shares of common stock.

Quipt Home Medical Corp., a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has acquired Great Elm Healthcare, LLC, a division of Great Elm Group, Inc., with an effective date of December 31, 2022.

Generation Bio Co. announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th at 4:30 p.m. PST in San Francisco, CA.